Pediatric ID News

The FDA recently approved two separate vaccines to prevent respiratory syncytial virus in older adults. Soon, additional RSV prevention tools may be available for pediatric patients, too.

An FDA advisory committee on Thursday voted in favor of approving the long-acting monoclonal antibody nirsevimab to protect neonates and infants from respiratory syncytial virus.

A review of nearly 250,000 doses of messenger RNA COVID-19 vaccine administered to young children identified no serious side effects from the shots, according to results published in Pediatrics.

Among more than 72,000 blood donors in the United States aged 16 years or older, 96% had antibodies against the virus that causes COVID-19 by late last year, according to a new analysis.

President Joe Biden is set to announce former North Carolina secretary of health Mandy K. Cohen, MD, MPH, as the next director of the CDC, according to multiple reports.

There were increases in rare pediatric intracranial infections over the past 3 years that coincided with notable spikes in respiratory viruses, although the infections remained rare, according to two reports published Thursday in MMWR.

A recent study of trends in HPV vaccine hesitancy found that the number of parents citing safety concerns as a reason not to vaccinate their children has increased.

A pentavalent vaccine against Neisseria meningitidis was shown to be safe and effective in a phase 3 trial conducted among children and young adults in Africa’s meningitis belt, researchers reported in The New England Journal of Medicine.

Gavi, the Vaccine Alliance forecasted that the global supply of oral cholera vaccine is likely to remain limited through 2025 if current outbreak trends continue.

New HIV infections in the United States declined by around 12% from 2017 to 2021, led by large decreases among young people, according to CDC data published Tuesday.